慢性乙型肝炎肝内胆汁淤积性黄疸发病机制的研究概况

杨宗国; 陈晓蓉; 刘成

慢性乙型肝炎肝内胆汁淤积性黄疸发病机制的研究概况

上海市公共卫生临床中心

基金项目:

中医药防治艾滋病、病毒性肝炎等疾病临床科研一体化技术平台体系构建及应用研究(2009ZX10005-019)；

详细信息

中图分类号: R714.2
计量
- 文章访问数: 4167
- HTML全文浏览量: 16
- PDF下载量: 732
- 被引次数: 0
出版历程
- 出版日期: 2011-12-20

The research advancement of pathogenesis of intrahepatic cholestasis jaundice related to chronic hepatits B

Research funding:

摘要

摘要: 慢性乙型肝炎致肝内胆汁淤积性黄疸的发病机制极其复杂,其中肝细胞凋亡、氧化应激及脂质过氧化、巨噬细胞介导的炎症反应等途径均参与肝内胆汁淤积性黄疸的发病。明确肝内胆汁淤积性黄疸的发病机制对临床靶点治疗有重要意义。
- 肝炎,乙型,慢性 /
- 胆汁淤积,肝内 /
- 细胞凋亡
Abstract: The pathogenesis of intrahepatic cholestasis jaundice caused by chronic hepatits B is extremely complicated, and the following pathways such as hepatocytes apoptosis, oxidative stress, lipid peroxidation and inflammatory response mediated by macrophage have a close link with the pathogenesis of intrahepatic cholestasis jaundice.To have a clear and complete definition on the pathogenesis of intrahepatic cholestasis jaundice is of great significance for its clinical target therapy.
- hepatitis B /
- chronic /
- cholestasis

HTML全文

参考文献(30)

[1]Rutherford AE, Pratt DS.Cholestasis and cholestatic syndromes[J].Curr Opin Gastroenterol, 2006, 22 (3) :209-214.

[2]苏先狮.胆汁淤积性黄疸的诊断和治疗[J].临床肝胆病杂志, 2005, 21 (3) :137-138.

[3]Liu Q, Shen WF, Sun HY, et al.Hydrogen-rich saline pro-tects against liver injury in rats with obstructive jaundice[J].Liver Int, 2010, 30 (7) :958-968.

[4]McNeilly AD, Macfarlane DP, O’Flahert E, et al.Bile acids modulate glucocorticoid metabolism and the hypothalamic-pituitary-adrenal axis in obstructive jaundice[J].J Hepa-tol, 2010, 52 (5) :705-711.

[5]Zollner G, Trauner M.Mechanisms of Cholestasis[J].Clin Liver Dis, 2008, 12 (1) :1-26.

[6]Wagner M, Zollner G, Trauner M.New molecular insights into the mechanisms of cholestasis[J].J Hepatol, 2009, 51 (3) :565-580.

[7]Floreani A, Guido M, Bortolami M, et al.Relationship be-tween apoptosis, tumour necrosis factor, and cell prolifera-tion in chronic cholestasis[J].Diges Liver Dis, 2001, 33 (7) :570-575.

[8]Gores GJ.Mechanisms of cell injury and death in cholestasis and hepatoprotection by ursodeoxycholic acid[J].J Hepa-tol, 2000, 32 (Suppl2) :11-13.

[9]Pasquetto V, Wieland S, Chisari FV.Intracellular hepatitis B virus nucleocapsids survive cytotoxic T-lymphocyte-in-duced apoptosis[J].J Virol, 2000, 74 (20) :9792-9796.

[10]Schurich A, Khanna P, Lopes AR, et al.Role of the Coinhib-itory Receptor Cytotoxic T Lymphocyte Antigen-4on Apop-tosis-Prone CD8T Cells in Persistent Hepatitis B Virus In-fection[J].Hepatology, 2011, 53 (5) :1494-1503.

[11]Lu YW, Chen WN.Human hepatitis B virus X protein in-duces apoptosis in HepG2cells:Role of BH3domain[J].Biochem Bioph Res Co, 2005, 338 (3) :1551-1556.

[12]Lu YW, Ren YD, Bai J, et al.The spliced variant of hepatitis B virus protein, HBSP, interacts with Bcl-2/Bcl-xl in vitro and induces apoptosis in HepG2cells[J].IUBMB Life, 2008, 60 (10) :700-702.

[13]Ehrmann JJr, GaluszkováD, Ehrmann J, et al.Apoptosis-related proteins, BCL-2, BAX, FAS, FAS-L and PCNA in liver biopsies of patients with chronic hepatitis B virus infec-tion[J].Pathol Oncol Res, 2000, 6 (2) :130-135.

[14]Clippinger AJ, Gearhart TL, Bouchard MJ.Hepatitis B virus X protein modulates apoptosis in primary rat hepatocytes by regulating both NF-kappa B and the mitochondrial permea-bility transition pore[J].J Virol, 2009, 83 (10) :4718-4731.

[15]Shi H, Guan SH.Increased apoptosis in HepG2.2.15cells with hepatitis B virus expression by synergistic induction of interferon-gamma and tumour necrosis factor-alpha[J].Liver Int, 2009, 29 (3) :349-355.

[16]Gores GJ.Fas-mediated apoptosis as a mechanism of liver injury in cholestasis[J].Faseb J, 2001, 15 (5) :A1070-A1070.

[17]Tang TJ, Kwekkeboom J, Laman JD, et al.The role of intra-hepatic immune effector cells in inflammatory liver injury and viral control during chronic hepatitis B infection[J].J ViralHepatitis, 2003, 10 (3) :159-167.

[18]梁扩寰, 李绍白.肝脏病学[M].第2版, 北京:人民卫生出版社, 2006:515-561.

[19]Perez-mera RA, Shields CE.Jaundice associated with no-rethindrone acetate therapy[J].N Engl J Med, 1962, 267:1137-1138.

[20]Stieger B, Fattinger K, Madon J, et al.Drug-and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt export pump (Bsep) of rat liver[J].Gastroenterol-ogy, 2000, 118 (2) :422-430.

[21]Cao JS, Wood M, Liu Y, et al.Estradiol represses prolactin-induced expression of Na+/taurocholate cotransporting polypeptide in liver cells through estrogen receptor-alpha and signal transducers and activators of transcription5a[J].Endocrinology, 2004, 145 (4) :1739-1749.

[22]Ruiz ML, Villanueva SSM, Luquita MG, et al.Beneficial effect of spironolactone administration on ethynylestradiol-induced Cholestasis in the rat:Involvement of up-regulation of multi-drug resistance-associated protein2[J].Drug Metab Dispos, 2007, 35 (11) :2060-2066.

[23]Zollner G, Fickert P, Zenz R, et al.Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases[J].Hepatology, 2001, 33 (3) :633-46.

[24]Noe J, Hagenbuch B, Meier PJ, et al.Characterization ofthe mouse bile salt export pump overexpressed in the bacu-lovirus system[J].Hepatology, 2001, 33 (5) :1223-1231.

[25]陈芸, 王小众.HBV X蛋白与氧化应激的相关性[J].胃肠病学和肝病学杂志, 2009, 18 (2) :174-177.

[26]王凯, 王兵, 范晓鹏, 等.慢性乙型肝炎患者氧化损伤的研究[J].中华实验和临床病毒学杂志, 2004, 18 (2) :172-174.

[27]Rost D, Welker A, Berger I, et al.319Cholestasis and downregulation of bile acid transporters in a novel in vivo model of sustained non-toxic oxidative stress (H 2 O 2) [J].J Hepatol, 2006, 44 (Suppl2) :S123-S123.

[28]Copple BL, Jaeschke H, Klaassen CD.Oxidative stress and the pathogenesis of cholestasis[J].Semin Liver Dis, 2010, 30 (2) :195-204.

[29]Moazzam FN, Brems JJ, Yong SL, et al.Endotoxin potenti-ates hepatocyte apoptosis in cholestasis[J].J Am Coll Sur-geons, 2002, 194 (6) :731-739.

[30]Korolenko TA, Klishevich MS, Cherkanova MS, et al.In Vivo Effect of Selective Macrophage Suppression on the Develop-ment of Intrahepatic Cholestasis in Mice[J].B Exp Biol Med, 2008, 146 (4) :396-400.

施引文献

资源附件(0)

访问统计